Literature DB >> 17208078

A comparison of acute coronary syndrome care at academic and nonacademic hospitals.

Manesh R Patel1, Anita Y Chen, Matthew T Roe, E Magnus Ohman, L Kristin Newby, Robert A Harrington, Sydney C Smith, W Brian Gibler, James E Calvin, Eric D Peterson.   

Abstract

PURPOSE: Although adherence to guidelines recommendations is assumed to be more difficult for nonacademic community hospitals, patterns of adherence have not been evaluated by hospital type. We sought to identify hospital characteristics associated with high levels of adherence in order to gain insight into successful processes of care.
METHODS: From January 2001 through March 2004, we analyzed data from 86,042 patients in the CRUSADE Initiative with high-risk non-ST-segment elevation acute coronary syndromes (NSTE ACS) defined by positive cardiac markers or ischemic ST-segment changes. Academic sites were defined by Council of Teaching Hospital affiliation in the American Hospital Association database. Adherence was determined for each hospital based on guidelines recommendations for the use of 4 acute (<24 hrs) and 5 discharge therapies in patients without contraindications. Multivariable modeling was used to standardize hospital estimates for patient characteristics and control for clustering within centers.
RESULTS: A total of 60,285 patients were admitted to nonacademic hospitals (n=355), and 25,757 were admitted to academic hospitals (n=125). Academic hospitals were larger (median 500 vs 268 beds, P <.001) and more often had bypass services (88% vs 60%, P <.001). Composite adherence to recommended therapies was slightly higher at academic vs. nonacademic hospitals (median 77.8% vs 73.7%, P <0.01), and variance in individual hospital performance was greater among nonacademic sites. Nonacademic hospitals accounted for 15 of the 20 highest performing sites and 19 of the 20 lowest performing sites. In-hospital clinical outcomes, including cardiogenic shock, stroke, and death were similar for patients admitted to both types of hospital.
CONCLUSION: Adherence to American College of Cardiology and American Heart Association (ACC/AHA) guidelines for NSTE ACS care at academic hospitals is slightly higher than at nonacademic hospitals; however there is significant room for improvement within both systems. The larger performance variation in care among nonacademic hospitals highlights the need for continued emphasis on consistent care processes.

Entities:  

Mesh:

Year:  2007        PMID: 17208078     DOI: 10.1016/j.amjmed.2006.10.008

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

1.  Screening high risk individuals for hepatitis B: physician knowledge, attitudes, and beliefs.

Authors:  Temitope Foster; Huiming Hon; Fasiha Kanwal; Steven Han; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2011-10-15       Impact factor: 3.199

2.  Association Between Treatment by Locum Tenens Internal Medicine Physicians and 30-Day Mortality Among Hospitalized Medicare Beneficiaries.

Authors:  Daniel M Blumenthal; Andrew R Olenski; Yusuke Tsugawa; Anupam B Jena
Journal:  JAMA       Date:  2017-12-05       Impact factor: 56.272

3.  Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines.

Authors:  Carol M Lewis; Amy C Hessel; Dianna B Roberts; Yunxia Z Guo; F Christopher Holsinger; Lawrence E Ginsberg; Adel K El-Naggar; Randal S Weber
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-12

4.  Comparison of documentation and evidence-based medicine use for non-ST-segment elevation myocardial infarction among cardiology, teaching, and nonteaching teams.

Authors:  Austin Metting; Daniel Binz; Colleen Y Colbert; Juhee Song; Chris Chiles; Curtis Mirkes
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-07

5.  Persistence of evidence-based medication use after discharge from academic versus nonacademic hospitals among patients with non-ST-segment elevation myocardial infarction.

Authors:  Jennifer Rymer; Lisa A McCoy; Laine Thomas; Eric D Peterson; Tracy Y Wang
Journal:  Am J Cardiol       Date:  2014-08-27       Impact factor: 2.778

6.  Does partial nephrectomy at an academic institution result in better outcomes?

Authors:  Quoc-Dien Trinh; Jan Schmitges; Maxine Sun; Jesse Sammon; Shahrokh F Shariat; Shyam Sukumar; Kevin Zorn; Marco Bianchi; Claudio Jeldres; Paul Perrotte; Markus Graefen; Craig G Rogers; James O Peabody; Mani Menon; Pierre I Karakiewicz
Journal:  World J Urol       Date:  2011-09-09       Impact factor: 4.226

Review 7.  A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?

Authors:  Neil S Maitra; Dhruv Mahtta; Sankar Navaneethan; Elizabeth M Vaughan; Ajar Kochar; Martha Gulati; Glenn N Levine; Laura A Petersen; Salim S Virani
Journal:  Curr Cardiol Rep       Date:  2022-03-29       Impact factor: 3.955

8.  Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.

Authors:  Marco Bianchi; Quoc-Dien Trinh; Maxine Sun; Malek Meskawi; Jan Schmitges; Shahrokh F Shariat; Alberto Briganti; Zhe Tian; Claudio Jeldres; Shyam Sukumar; James O Peabody; Markus Graefen; Paul Perrotte; Mani Menon; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

9.  Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures.

Authors:  Kimberly N Weaver; Michael D Kappelman; Robert S Sandler; Christopher F Martin; Wenli Chen; Kristen Anton; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

10.  Management of acute coronary syndrome in South Africa: insights from the ACCESS (Acute Coronary Events - a Multinational Survey of Current Management Strategies) registry.

Authors:  Colin Schamroth
Journal:  Cardiovasc J Afr       Date:  2012-03-13       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.